Curie Co
Curie Co engineers enzymes and bio-based preservation systems to replace banned or harmful chemicals in consumer products, serving personal care, food and beverage, home care, paints and coatings, and textile manufacturers through B2B ingredient sales.
- Company typePrivate
- Founded2017
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Curie Co does
Curie Co is a privately-held life science company founded in 2017 and headquartered in Research Triangle Park, North Carolina (relocated from New York in 2022 to scale biomanufacturing). The company engineers enzymes and develops "conscious chemistry" preservation systems designed to replace legacy chemicals facing regulatory and consumer pressure in consumer goods products. Its proprietary platform combines directed evolution of enzymes, cell-free protein synthesis, automated iterative screening, and microbial biomanufacturing to produce specialty ingredients at commercial scale using existing pharmaceutical and specialty chemical manufacturing infrastructure.
The company sells ingredients through a B2B model to consumer goods brands and ingredient manufacturers across five verticals: personal care (haircare active Curamina, preservation system AmpliPQ and AmpliPQ-CF), food and beverage (dairy process enzyme Curabind), home care and industrial cleaning (preservation system Evogard), paints and coatings (preservation system Evogard), and leather and textiles. Revenue is generated through ingredient sales, with channel partners playing a significant role — TCR Industries holds exclusive distribution rights for Curamina in the Western and Southwestern United States, and Microban International serves as a strategic partner for global preservation solutions across HI&I, paints, and coatings. Pricing is quote-based and not publicly disclosed.
Curie Co has launched five branded products between March 2024 and early 2026 and currently operates with 11-50 employees. The company is led by founder and CEO Erika Milczek, PhD, alongside CFO/COO Sarvin Patel (MBA) and Bioprocess lead Neal Connors, PhD. Total disclosed funding is approximately $1.42M from National Science Foundation grants, with additional undisclosed seed participation from Breakout Labs, Breakout Ventures, Cantos, Joyance Partners, and Social Starts.
Curie Co firmographics
Firmographics- Name
- Curie Co
- Legal name
- Curie Co. Inc.
- Website
- https://curieco.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Curie Co engineers enzymes and bio-based preservation systems to replace banned or harmful chemicals in consumer products, serving personal care, food and beverage, home care, paints and coatings, and textile manufacturers through B2B ingredient sales.
- Ownership category
- akta.pro rank
Curie Co industry classification
Industry- Product category
- Industrial Biotechnology Ingredients
- NAICS
- Soap and Cleaning Compound Manufacturing (32561), Food Manufacturing (311)
- SIC
- Miscellaneous Chemical Products (2890), Food And Kindred Products (2000)
- akta.pro primary industry
- Personal Care & Cosmetic Ingredients (IMAEABAJ)
- akta.pro secondary industry
- Salt, Acids & pH Regulators (Citric/Lactic/Phosphoric, Buffers) (CRADAOAC)
Keywords
Where Curie Co is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Curie Co business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Ingredient Sales: B2B ingredient company selling biosolutions and greener chemistries to consumer goods manufacturers. Products include Curamina (haircare active), Curabind (food & beverage enzyme), AmpliPQ and Evogard (preservation systems). Revenue is generated through ingredient sales to manufacturers across personal care, food & beverage, home care, paints & coatings, and leather & textiles industries.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Curie Co product offering
Product offeringCore offering
Curie Co engineers and manufactures proprietary bio-based ingredients — including enzymes and preservation chemistries — that replace legacy, regulated, or banned chemicals in consumer products. Its products are sold as functional ingredients to consumer goods manufacturers across personal care (Curamina), food & beverage (Curabind), and preservation applications in personal care, HI&I, and paints & coatings (AmpliPQ, AmpliPQ-CF, Evogard).
Product overview
Curie Co is a biotechnology company that develops novel biosolutions and conscious chemistry alternatives to replace legacy chemicals in consumer products. The company offers a portfolio of branded ingredients across two technology platforms: biosolutions (Curamina, Curabind) that leverage engineered enzymes for hair care and food & beverage applications, and conscious chemistry (AmpliPQ, Evogard, AmpliPQ-CF) that provide preservation systems for personal care, home care, and industrial applications. Curie Co's products target legacy chemicals facing regulatory and consumer pressure, offering eco-friendly alternatives without compromising performance or cost-in-use.
Differentiator
Problem solved
Functional benefit
Brands
- Curamina: Haircare active ingredient - next generation bond building technology for hair care, a dual action bioactive designed to work with protein ingredients to support hair health, styling, and manageability.
- Curabind
- AmpliPQ
- Evogard
Products and services
- Curamina The next generation of bond building technology for hair care — a dual action bioactive designed to work with protein ingredients to support hair health, styling, and manageability. Targeted at consumer goods brands in beauty and personal care.
- Curabind A clean-label enzyme designed to improve the yield and stability of dairy products. Increases throughput and reduces waste with no additional equipment, label change, or CapEx. Targets food and beverage manufacturers.
- AmpliPQ Modern preservation system that extends the antimicrobial protection of organic acids, enabling use across personal care, HI&I, paint & coating applications. Targeted at personal care and home care product manufacturers.
- Evogard Preservation solutions for household, industrial, and institutional cleaners as well as paints and coatings, expanding the use of organic acids into new applications. Targeted at HI&I and coatings manufacturers.
- AmpliPQ-CF Clean, effective preservation for beauty products that boosts the efficacy of sodium benzoate in formulations, enabling robust, broad-spectrum protection with competitive cost-in-use. Targeted at beauty and personal care brands.
Quantifiable outcome
- Process yields cost-effective biobased ingredients that are orders of magnitude better than chemicals with net positive environmental impact
Companies that use Curie Co
Customer profileSegments5 records
Ideal customer profiles3 records
Curie Co technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Curie Co partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Microban InternationalcoreStrategic partnership to deliver cutting-edge preservation systems for household, industrial, and institutional cleaners, as well as paints and coatings. Curie Co introduces Evogard and custom preservation solutions, expanding the use of organic acids into new applications through this collaboration.
- TCR IndustriescoreTCR Industries serves as the exclusive distributor for Curamina, covering the Western and Southwestern United States. This distribution partnership expands market reach for Curie Co's haircare active ingredient.
Scale indicators1 record
Recent moves7 records
Expansion highlights5 records
Curie Co competitors and assessment
Company assessmentDirect peers
- Codexis: Codexis engineers novel enzymes using directed evolution and sells them into pharma and food ingredients. Most directly comparable to Curie Co on core technology (directed evolution) and ingredient business model, though Codexis is more pharma-weighted.
- Conagen: Conagen uses precision fermentation and enzyme engineering to develop specialty ingredients for food, personal care, and industrial customers. Closely comparable to Curie Co on technology platform and B2B ingredient go-to-market.
- Geltor: Geltor uses synthetic biology to produce animal-free proteins for personal care and food customers. Comparable to Curie Co on biotech-derived, sustainability-positioned ingredients sold into beauty and F&B brand owners.
Broad incumbents
- Novonesis (formerly Novozymes): World's largest industrial enzyme producer with deep presence across food, personal care, home care, and textiles. Represents the scaled incumbent benchmark that Curie Co's enzyme platform ultimately competes against for manufacturer wallet share.
- DSM-Firmenich: Global ingredients giant combining DSM's nutrition and enzyme portfolio with Firmenich's flavors and fragrances. Comparable to Curie Co across personal care, food & beverage, and preservation customers, but at vastly greater scale.
- International Flavors & Fragrances (IFF): IFF's Health & Biosciences division supplies enzymes and cultures to food, beverage, and home care customers, while the company also serves personal care with flavors and actives. Direct overlap with Curie Co on preservation and ingredient supply into CPG.
- BASF: BASF's Care Chemicals and Nutrition & Health divisions supply personal care ingredients, preservation systems, and food enzymes globally. Represents a deep-pocketed, full-portfolio incumbent in every vertical Curie Co targets.
- Ginkgo Bioworks: Ginkgo operates a synthetic biology platform that programs cells for ingredient and enzyme production across food, personal care, and industrial customers. Comparable on platform-based biotech R&D, though Ginkgo operates at a different scale and stage.
- Lonza: Lonza supplies specialty ingredients including preservation systems and personal care actives to global brand owners. Overlaps with Curie Co in personal care and HI&I preservation chemistries, with substantially greater commercial and regulatory infrastructure.
Emerging players
- Locus Fermentation Solutions: Locus Fermentation Solutions produces microbe-based specialty ingredients for personal care, food, and industrial applications. Comparable emerging biotech supplier selling sustainable, fermentation-derived ingredients into overlapping customer segments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Curie Co social profiles
Digital presenceCurie Co financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curie Co leadership team
Management profileNumber of profiles
Profiles4 records
Curie Co funding detail
Funding detailFunding overview
Funding rounds4 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curie Co M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curie Co
What does Curie Co do?
Curie Co engineers and manufactures proprietary bio-based ingredients — including enzymes and preservation chemistries — that replace legacy, regulated, or banned chemicals in consumer products. Its products are sold as functional ingredients to consumer goods manufacturers across personal care (Curamina), food & beverage (Curabind), and preservation applications in personal care, HI&I, and paints & coatings (AmpliPQ, AmpliPQ-CF, Evogard).
Is Curie Co a public or private company?
Curie Co is a private company. It is classified as venture growth investor backed and is currently operating.
When was Curie Co founded?
Curie Co was founded in 2017. It employs 11 to 50 people.
Where is Curie Co based?
Curie Co is headquartered in New York, United States, in the North America region.
How does Curie Co make money?
One revenue line is on record: ingredient Sales.
Who are Curie Co's main competitors?
Direct peers on record are Codexis, Conagen and Geltor. Broad incumbents are Novonesis (formerly Novozymes), DSM-Firmenich, International Flavors & Fragrances (IFF), BASF, Ginkgo Bioworks and Lonza. Locus Fermentation Solutions is listed as an emerging player.
Does Curie Co have an API?
No public API is recorded for Curie Co.
What industry is Curie Co in?
Curie Co's product category is Industrial Biotechnology Ingredients. Its primary akta.pro industry code is IMAEABAJ, Personal Care & Cosmetic Ingredients, with a secondary code of CRADAOAC, Salt, Acids & pH Regulators (Citric/Lactic/Phosphoric, Buffers). Its NAICS code is 32561 and its SIC code is 2890.